Close Menu

NEW YORK (GenomeWeb) – Mobidiag, a Finnish molecular diagnostics maker, has entered an agreement with Chinese clinical diagnostics firm Autobio Diagnostics to establish a joint venture in China. Separately, Autobio Diagnostics has made a €10 million ($11.3 million) equity investment in Mobidiag, the firms announced today.

Mobidiag and Autobio will invest a total of €12.3 million to establish the joint venture company, with Autobio investing €8 million in the JV for a 65 percent stake, and Mobidiag investing €4.3 million for a 35 percent stake. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
16
Sponsored by
ArcherDX

This webinar will discuss a next-generation sequencing approach for detecting genomic mutations in hematologic maglignancies.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.